期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 522, 期 1-3, 页码 130-138出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2005.08.045
关键词
histamine H-4 receptor antagonist; JNJ 7777120; JNJ 10191584; colitis; inflammatory bowel disease; neutrophil; tumour necrosis factor-alpha
The histamine H-4 receptor is a G-protein coupled receptor with little homology to the pro-inflammatory histamine H, receptor, expressed on cells of the immune system with hematopoietic lineage such as eosinophils and mast cells. The effects of the recently described highly selective histamine H-4 receptor antagonists JNJ 10191584 and JNJ 7777120 have now been investigated on the acute colitis provoked by trinitrobenzene sulphonic acid over 3 days in the rat. Treatment with JNJ 10191584 (10-100 mg/kg p.o., b.i.d.) caused a dose-dependent reduction in macroscopic damage, inhibition of the TNBS-provoked elevation of both colonic myeloperoxidase and tumour necrosis factor-alpha (TNF-alpha), and a reduction in the histologically assessed increase in mucosal and submucosal thickness and neutrophil infiltration. JNJ 7777120 (100 mg/kg p.o., b.i.d.) likewise reduced the macroscopic injury and the increases in colonic myeloperoxidase and TNF-alpha levels. These findings indicate a pro-inflammatory role for the histamine H-4 receptor in this model and suggest a novel pharmacological approach to the treatment of colitis. (c) 2005 Elsevier B.V All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据